Skip to main navigation Skip to search Skip to main content

Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs

Research output: Contribution to journalArticlepeer-review

Abstract

Antiretroviral treatment is highly effective in enhancing HIV-positive patients' survival and quality of life. Despite an increased tolerability in recent years, a substantial amount of patients experience side effects. Antiretrovirals' efficacy and tolerability have been associated with plasma concentrations and single nucleotide polymorphisms in selected genes involved in drug disposition.
Original languageEnglish
Pages (from-to)355-369
Number of pages15
JournalClinical Pharmacokinetics
Volume56
Issue number4
DOIs
Publication statusPublished - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs'. Together they form a unique fingerprint.

Cite this